SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VD's Model Portfolio & Discussion Thread

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Andrew H who wrote (2360)9/12/1997 12:15:00 AM
From: squetch   of 9719
 
>>suggests checking out CEGE<< I think you mean CELG. I thought I mixed it up myself the other day.(:>) I think the info on BTGC/CELG thread, if accurate, takes away one of the risk factors of three I saw. I would like more info on OxSODrol. IF it works, BTGC will likely rocket higher as BPD market is est ~750M. OxSODrol would have 7 years as Orphan. The other factor is they are located in Israel. Just a risk, but what is life w/out risks.(:>) THe only other thing I don't like is SP covers it so every Tom, Dick, and Harry knows about it.

FWIW, David S. had VENTUS called correctly. I noticed he is changing his tune on Synovir(thalidomide) for AIDS wasting. Regards, squetch
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext